738 related articles for article (PubMed ID: 27260134)
1. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
O'Connor TF; Yu LX; Lee SL
Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
[TBL] [Abstract][Full Text] [Related]
2. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
3. Emerging Technology as a Key Enabler for Modernizing Pharmaceutical Manufacturing.
Lee SL; Brorson K
PDA J Pharm Sci Technol; 2017; 71(2):66-67. PubMed ID: 28396563
[No Abstract] [Full Text] [Related]
4. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
Steinwandter V; Herwig C
PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
[TBL] [Abstract][Full Text] [Related]
5. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
[TBL] [Abstract][Full Text] [Related]
6. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
7. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
[TBL] [Abstract][Full Text] [Related]
8. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
9. Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.
Fisher AC; Lee SL; Harris DP; Buhse L; Kozlowski S; Yu L; Kopcha M; Woodcock J
Int J Pharm; 2016 Dec; 515(1-2):390-402. PubMed ID: 27773853
[TBL] [Abstract][Full Text] [Related]
10. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
11. FDA pharmaceutical quality oversight.
Yu LX; Woodcock J
Int J Pharm; 2015 Aug; 491(1-2):2-7. PubMed ID: 26027494
[TBL] [Abstract][Full Text] [Related]
12. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Badman C; Trout BL
J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
[No Abstract] [Full Text] [Related]
13. Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group.
Weitzel J; Pappa H; Banik GM; Barker AR; Bladen E; Chirmule N; DeFeo J; Devine J; Emrick S; Hout TK; Levy MS; Mahlangu GN; Rellahan B; Venema J; Workman W
AAPS J; 2021 Oct; 23(6):112. PubMed ID: 34654974
[TBL] [Abstract][Full Text] [Related]
14. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
Konstantinov KB; Cooney CL
J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
[TBL] [Abstract][Full Text] [Related]
15. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
Garcia FA; Vandiver MW
PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
[TBL] [Abstract][Full Text] [Related]
16. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside.
Rahman Z; Barakh Ali SF; Ozkan T; Charoo NA; Reddy IK; Khan MA
AAPS J; 2018 Sep; 20(6):101. PubMed ID: 30209693
[TBL] [Abstract][Full Text] [Related]
17. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
18. Solving the Global Continual Improvement and Innovation Challenge: How an Effective Pharmaceutical Quality System Can Transform Post-Approval Change Management.
Vinther A; Ramnarine E
PDA J Pharm Sci Technol; 2019; 73(5):517-521. PubMed ID: 31420505
[TBL] [Abstract][Full Text] [Related]
19. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
20. A practical discussion of risk management for manufacturing of pharmaceutical products.
Mollah AH; Baseman HS; Long M; Rathore AS
PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
